AlphaMadera's AlphaVal page computes Travel + Leisure Co.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag TNL as undervalued, fairly valued, or overvalued.

What is Travel + Leisure Co.'s fair value?

Fair value for TNL is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value TNL?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from TNL's most recent reported fundamentals.

TNL - Travel + Leisure Co.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $86.88 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Moderate

Trading 17.8% below fair value

Current Price $73.35

Bear Case $71.36 2.7% downside ($71.36 - $73.35) / $73.35 = -2.7% $4.75 × 15x P/E

Fair Value $89.20 21.6% upside ($89.20 - $73.35) / $73.35 = 21.6% $4.75 × 19x P/E

Bull Case $107.04 45.9% upside ($107.04 - $73.35) / $73.35 = 45.9% $4.75 × 23x P/E

Adjust Assumptions

P/E Multiple

18.9x

Adjusted EPS

4.75$

Key Value Driver

Normalized P/E multiple (19x base case)

Implied Market Multiple 15.4x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $86.88 from 15 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $89.20 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 38%. Check what costs are being left out of the adjusted number.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples